Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Share Repurchase Program

INFORMATION REGLEMENTEE


[24/03/2020 | 20:00]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6engt63kmMNk8FyrXjhp9r36OAlyyC7FwUcwOu7zzJau6NA3y41e7DEk=
lkCxy9Fab0jOgC5zPbwrYWoxZSu4ef1weH4p_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7Ki=
DwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wa=
ADRuVUcINrIa-2FMC6vnaaxtyRUoXDE40BDwotvtK2V86a3-2Fr-2BkQMWM9RUvq-2Bm-2Baw4G=
R-2BIWZqL29GhpGckYg-2Fgs4VBzWJ8v7TLOdGlXQdN124egO75dv9PBBibT4vQziouM4mMnT-2=
Bl-2BTzYQjW74f2F0N8S8BWi5errC4pbbeqnvXyy-2FfZuKtMpgqYd1FqaC5VZHc1FggNvttjZJ=
wq4cn1cp59xaueE3DMCPMZeBEVCXAZFK5A-2Baagx6ljLkKRP7n7Q-3D

** Share Repurchase Program to cover UCB's Long Term Incentive Plans for it=
s employees
------------------------------------------------------------

Brussels (Belgium), 24 March 2020 =E2=80=93 20:00 (CET) =E2=80=93 regulated=
information

In application of article 7:215 of the Belgian Code of Companies and Associ=
ations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =E2=80=9CCompany) (Euronext=
Brussels: UCB) announces the launch of a share buy-back program (the =E2=
=80=9CShare Repurchase Program 2020=E2=80=9D), effective as of 25 March 202=
0.=C2=A0

The repurchase of UCB shares under this program intends to cover current an=
d future obligations under UCB's Long Term Incentive Plans for its employee=
s. UCB will continuously monitor both its current and future obligations un=
der such plans in view of keeping an adequate level of treasury shares.

Under this program, UCB may acquire from time to time its common stock, for=
a maximum of 1.2 million shares. The share repurchases will be conducted u=
nder the terms and conditions approved by the extraordinary general shareho=
lders=E2=80=99 meeting of the Company held on 26 April 2018. The timing of =
the repurchase of shares pursuant to the program will depend on a variety o=
f factors, including market conditions. The program may be suspended or dis=
continued at any time.

UCB has requested a financial intermediary to repurchase UCB shares on its =
behalf under the terms of an initial discretionary mandate agreement with v=
alidity until 15 June 2020.=C2=A0

During the Share Repurchase Program 2020, regular updates will be published=
in accordance with applicable legislation.

This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3DaCXr_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waADRuVUcINrIa-2FMC6=
vnaaxtyRUoXDE40BDwotvtK2V86a3-2Fr-2BkQMWM9RUvq-2Bm-2Baw4GR-2BIWZqL29GhpGckY=
g-2Fgs4VBzWJ8v7TLOdGlXQdN12yDFJ-2B2s2emlj-2Bp8NkYsQfHTitsTMHokrFleV83-2F1VB=
0HY4PUMoKpn32itzM-2B9K3hRcqRaNgrcsYJrFQ7BxiNuFgi0uR-2FnF2y-2F-2BW7yHDqLYQvE=
oyCyEkAgyVFTDZEA5BKUOkVWObKhX2hqFZztFsX7Y-3D .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news
=C2=A0
GenericFile
20200324 UCB Share Repurchase Program 2020 ENG final (https://u7061146.ct.s=
endgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6e=
ngt63kmMNk8FyrXjhp9r369gNjchgxsfkzhwWbr7jihQ-2B3yKuMQyhPaOVh39HZoZU-3DEQFL_=
xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2F=
BZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waADRuVUcINrIa-2FMC6vnaaxtyRUoXDE40BDwo=
tvtK2V86a3-2Fr-2BkQMWM9RUvq-2Bm-2Baw4GR-2BIWZqL29GhpGckYg-2Fgs4VBzWJ8v7TLOd=
GlXQdN12wBavAPxAEo5Gqu7VM3juWcmKhD6U38NmOHwVjAA8a-2F08h5Jz9GkaOpNyqHNzJc3ZA=
pGYUYjLmE2ZmMs71-2FDqyXMY-2FA5dma9y8pHbM12-2BaIJH-2B7AaEmw4KLIZpcaASFiF1J-2=
BV2ZM-2Fws-2FUptoDuyfe9c-3D GenericFile
20200324 UCB Aandelen Inkoop Programma 2020 NED Final (https://u7061146.ct.=
sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6=
engt63kmMNk8FyrXjhp9r36wB1WuDD39Wx63mOQMtK4-2BLL33V-2BIuQiesjmfFKFnwlo-3DO2=
oX_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW=
-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waADRuVUcINrIa-2FMC6vnaaxtyRUoXDE40B=
DwotvtK2V86a3-2Fr-2BkQMWM9RUvq-2Bm-2Baw4GR-2BIWZqL29GhpGckYg-2Fgs4VBzWJ8v7T=
LOdGlXQdN123G4YzX4gz8BWy6qZpD-2BZeTvd4shlDBo1RcI2ES-2FjkgXtn3QbD-2BG9WX3mtO=
rE2NLD0Q4yO9bi9q-2BRVaaLVzXYFIZT7w3JEt9czgeG5PXjIL6gFAf73usRnGS6-2FtVvjl3c-=
2FDDFAM0oX4Iw-2BbphvLjLXE-3D GenericFile
20200324 - UCB Programme de rachat d actions propres 2020 FR Final (https:/=
/u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2=
ORJ-2Fb7C-2B6engt63kmMNk8FyrXjhp9r36ow16WGFf2xcUr2Nzk2SvJss1hdGnUKAvacoLCI5=
e5lc-3DLZbB_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs=
6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waADRuVUcINrIa-2FMC6vnaaxty=
RUoXDE40BDwotvtK2V86a3-2Fr-2BkQMWM9RUvq-2Bm-2Baw4GR-2BIWZqL29GhpGckYg-2Fgs4=
VBzWJ8v7TLOdGlXQdN12-2FN80tAP4IcPWRBaEus-2BQqAvaYql-2BBYxdVJCiGnKSLVZSvwKbo=
JYVKTgfNDpTMWfF9wcpY8G0rF4trjXDZrLhsZ-2BIP4uZFlTCLpMWaz4SpyUOGkSvbcWdUL3ckS=
WdMvCEhyaE7-2Fc9bm694fAPE8ahXk-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcX49gJvK-2FL-2FWuR43AT5QGgxrR4KR2=
Xp-2FBDB3qh7vjPFjRaYBevQXqcaxffpmQtlp3dbtjlt-2BqUjdSPS9sDAWxcXGTyLcX3RRZ3jZ=
G3dycm6kA-3DceuD_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0=
KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waADRuVUcINrIa-2FMC6vn=
aaxtyRUoXDE40BDwotvtK2V86a3-2Fr-2BkQMWM9RUvq-2Bm-2Baw4GR-2BIWZqL29GhpGckYg-=
2Fgs4VBzWJ8v7TLOdGlXQdN12zg4DDrXz0-2B-2FWe-2FHO7nNqw9fRLBptb3YmDR4Rhy31HbTQ=
PBZ7qY34EEqnTC5uEUgKMSwpDDVfRaPguMoH-2FVYPr3OqnopJG52jIWNZMCsjr4GBnB0XaDOUU=
n2bo1m8Vna2AQWdIuWGl0Z7WbjhLomgA0-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=